116 related articles for article (PubMed ID: 6284872)
1. Complement components in kidney allograft recipients: relationship to cytomegalovirus infection.
Chatterjee S; Fiala M; Arroyave C; Azen S; Cosgrove D
J Med Virol; 1982; 9(3):237-44. PubMed ID: 6284872
[TBL] [Abstract][Full Text] [Related]
2. Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation?
van Son WJ; van der Bij W; Tegzess AM; Anema J; van der Giessen M; van der Hem GK; Marrink J; The TH
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):109-21. PubMed ID: 2535976
[TBL] [Abstract][Full Text] [Related]
3. Complement activation associated with active cytomegalovirus infection in renal transplant patients, and its absence in transplant rejection episodes.
van Son WJ; van der Woude FJ; van der Hem GK; The TH; Ockhuizen T; Tegzess AM
Transplantation; 1985 May; 39(5):510-4. PubMed ID: 2986326
[TBL] [Abstract][Full Text] [Related]
4. Influence of age and sex on serum complement components in children.
Roach B; Kim Y; Jerome E; Michael AF
Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
[TBL] [Abstract][Full Text] [Related]
5. Complement changes in falciparum malaria infection.
Phanuphak P; Hanvanich M; Sakulramrung R; Moollaor P; Sitprija V; Phanthumkosol D
Clin Exp Immunol; 1985 Mar; 59(3):571-6. PubMed ID: 3886219
[TBL] [Abstract][Full Text] [Related]
6. In vitro complement activation by intercellular antibodies.
Hashimoto T; Sugiura M; Kurihara S; Nishikawa T
J Invest Dermatol; 1982 Apr; 78(4):316-8. PubMed ID: 6978365
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary dysfunction is common during a cytomegalovirus infection after renal transplantation even in asymptomatic patients. Possible relationship with complement activation.
van Son WJ; Tegzess AM; Hauw The T; Duipmans J; Slooff MJ; van der Mark TW; Peset R
Am Rev Respir Dis; 1987 Sep; 136(3):580-5. PubMed ID: 2820281
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of complement components in the course of type I (Lepra) and type II (ENL) reactions.
Sehgal VN; Sharma V; Sharma VK
Int J Dermatol; 1989; 28(1):32-5. PubMed ID: 2783924
[TBL] [Abstract][Full Text] [Related]
9. Complement components, C1 activation and disease activity in SLE.
Sturfelt G; Sjöholm AG; Svensson B
Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
[TBL] [Abstract][Full Text] [Related]
10. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
11. Breakdown product of factor B as an index of complement activation in lepromatous leprosy and its relation with bacillary load.
Saha K; Sharma V; Chakrabarty AK; Sehgal VN
Scand J Immunol; 1983 Jan; 17(1):37-43. PubMed ID: 6342123
[TBL] [Abstract][Full Text] [Related]
12. Antibody-independent binding and activation of complement by Schistosoma mansoni adult worms.
Linder E; Huldt G
Parasite Immunol; 1983 Mar; 5(2):183-94. PubMed ID: 6601790
[TBL] [Abstract][Full Text] [Related]
13. A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.
Praz F; Roque Antunes Barreira MC; Lesavre P
J Immunol Methods; 1982; 50(2):227-31. PubMed ID: 7045233
[TBL] [Abstract][Full Text] [Related]
14. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
[No Abstract] [Full Text] [Related]
15. Alternate and classical pathway components of complement in the normal cornea.
Mondino BJ; Ratajczak HV; Goldberg DB; Schanzlin DJ; Brown SI
Arch Ophthalmol; 1980 Feb; 98(2):346-9. PubMed ID: 6766301
[TBL] [Abstract][Full Text] [Related]
16. Methods to detect and quantitate complement activation.
Cooper NR; Nemerow GR; Mayes JT
Springer Semin Immunopathol; 1983; 6(2-3):195-212. PubMed ID: 6195745
[No Abstract] [Full Text] [Related]
17. Complement activation and C1q binding activity in haemodialysis.
Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
[No Abstract] [Full Text] [Related]
18. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
19. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary bypass and complement activation. Involvement of classical and alternative pathways.
Jones HM; Matthews N; Vaughan RS; Stark JM
Anaesthesia; 1982 Jun; 37(6):629-33. PubMed ID: 6920244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
